{"schema_version":"secwatch.filing_event.v1","accession":"0001193805-25-000454","form_type":"8-K","ticker":"IMUX","cik":"0001280776","company_name":"IMMUNIC, INC.","filed_at":"2025-04-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.826522+00:00","generated_at":"2026-05-23T18:01:39.959507+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Immunic prices $5.1M registered direct offering of 5.67M shares at $0.90/share","bullets":["Offering led by Aberdeen Investments; Titan Partners as placement agent.","Gross proceeds ~$5.1M; net proceeds ~$4.6M after commissions and expenses.","Shares sold at $0.90 per share under existing shelf registration statement.","Expected to close on April 10, 2025; proceeds to fund clinical trials and operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001193805-25-000454","json":"https://secwatch.observer/filing/0001193805-25-000454.json","markdown":"https://secwatch.observer/filing/0001193805-25-000454.md","text":"https://secwatch.observer/filing/0001193805-25-000454.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1280776/000119380525000454/0001193805-25-000454-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1280776/000119380525000454/e664373_8k-immunic.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T18:01:39.959507+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}